Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 191,900 shares, an increase of 76.9% from the February 13th total of 108,500 shares. Based on an average daily volume of 804,500 shares, the short-interest ratio is presently 0.2 days. Currently, 10.0% of the shares of the stock are short sold.
Vincerx Pharma Stock Up 1.0 %
Shares of VINC opened at $0.82 on Friday. Vincerx Pharma has a 12-month low of $0.75 and a 12-month high of $151.80. The business has a 50-day simple moving average of $1.82 and a two-hundred day simple moving average of $6.27. The stock has a market cap of $1.84 million, a PE ratio of -0.04 and a beta of 1.43.
Vincerx Pharma Company Profile
Featured Stories
- Five stocks we like better than Vincerx Pharma
- ESG Stocks, What Investors Should Know
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- How Investors Can Find the Best Cheap Dividend Stocks
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Vincerx Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vincerx Pharma and related companies with MarketBeat.com's FREE daily email newsletter.